Literature DB >> 27116997

Response of relapsed central nervous system hairy cell leukemia to vemurafenib.

Michael M McDowell1, Xiao Zhu1, Nitin Agarwal1, Marina N Nikiforova2, Frank S Lieberman3, Jan Drappatz3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27116997     DOI： 10.1080/10428194.2016.1177773

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

1.  Multifocal brain involvement in a patient with hairy cell leukemia successfully treated with rituximab and cladribine.

Authors:  Anamarija M Perry; Kant Matsuda; Vikram Wadhwa; Donna Hewitt; Muhamad Almiski; James B Johnston; Versha Banerji
Journal:  Blood Adv       Date:  2017-05-30

2.  BRAF in the cross-hairs.

Authors:  Mark B Geyer; Omar Abdel-Wahab; Martin S Tallman
Journal:  Expert Rev Hematol       Date:  2019-02-26       Impact factor: 2.929
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.